IONS – ionis pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Lou Gehrig's Disease Pipeline Landscape Report 2024: Therapeutic Assessment of 80+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type [Yahoo! Finance]
Here's Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 Weeks [Yahoo! Finance]
ExeVir Announces Michael Garrett as New Chief Executive Officer [Yahoo! Finance]
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its price target lowered by analysts at Piper Sandler from $65.00 to $62.00. They now have an "overweight" rating on the stock.
Flamingo Therapeutics Announces Oral Presentation at AACR Special Conference in Cancer Research on RNAs as Drivers, Targets, and Therapeutics in Cancer [Yahoo! Finance]
Form SC 13G/A IONIS PHARMACEUTICALS Filed by: BB BIOTECH AG
Form 4 IONIS PHARMACEUTICALS For: Nov 12 Filed by: LOSCALZO JOSEPH
Form 4 IONIS PHARMACEUTICALS For: Nov 12 Filed by: Monia Brett P
Form 4 IONIS PHARMACEUTICALS For: Nov 12 Filed by: Swayze Eric
Form SC 13G/A IONIS PHARMACEUTICALS Filed by: T. Rowe Price Investment Management, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.